Join Russell S. Weiner, Ph.D., FAAPS, AAPS President and several authors in Forum #1 in the Solution Center/Pavilion for a conversation about posters he is especially excited about relating to Novel Bioanalysis.
T1030-02-06 Qualification of the S-PLEX Neurology Panel 1 (GFAP, NfL and Tau) MSD Assay, Sreenivas Laxmanan, BioAgilytix
M1230-02-08 Comprehensive AAV-Based Vector Shedding Assessment by PCR: A Case Study with Whole Blood, Serum, Semen, Urine, and Buccal Swab, Mark Wissell, Ph.D., Eurofins Viracor BioPharma Services
M1330-02-08 Analysis of Pre-existing Anti-AAV Antibodies Using a Novel Nanoliter Total Antibody Assay: A Serotype-Independent Approach, Noah Kopcho, Ph.D., Gyros Protein Technologies
M1230-02-09 Bringing Unstable Flow Cytometry Assays Closer to the Patient: Case Study of an Ex Vivo CD11b Stimulation Flow Cytometry Assay Collected at External Clinical Site, Johannes Stanta, Celerion
M1030-02-06 The Importance of Pairing a Matrix with a Nucleic Acid Extraction Approach: Compilation of 66 Bioanalytical PCR (qPCR and dPCR) Validations, Mark Wissel, Ph.D., Eurofins Viracor BioPharma Services
